The observed significant correlation between high miR-493-3p levels and reduced patient survival in both HGSC and advanced breast cancer strengthens our hypothesis that decline of Mad2 protein via miRNA-mediated mechanisms contributes to tumor recurrence and poor therapeutic outcome. Here, MAD2L1 is linked to breast cancer.